Oakstone Intensive Review of Endocrinology and Metabolism 2025

Oakstone Intensive Review of Endocrinology and Metabolism 2025

Include: 30 videos + 1 pdf, size: 5.78 GB

 Target Audience: practicing endocrinologists

 Information:

Board-Focused Endocrinology Review

Sharpen your expertise with Cleveland Clinic’s Intensive Review of Endocrinology and Metabolism, a high- yield, case-based online video program designed to help you master key concepts for board prep and everyday care. Lecturers ensure you learn the latest while reinforcing best practices across the full spectrum of endocrinology.

In this focused continuing medical education course you’ll review:

• Thyroid & menopause: nodules, cancer, hyper/hypothyroidism, menopausal management
• Adrenal & hypertension: endocrine hypertension, adrenal insufficiency, CAH
• Metabolism & weight: hypoglycemia, obesity, metabolic complications
• Bone & calcium: osteoporosis, vitamin D deficiency, hyper/hypocalcemia
• Pituitary & gonads: male/female hypogonadism, pituitary disorders
• Diabetes: complications, insulin and incretin therapy updates
• Special populations: pediatric endocrine care, endocrine surgery, transgender health

Date of Original Release: December 31, 2025

Learning Objectives

At the conclusion of this activity, the participant will be able to:

• Summarize clinical practice issues associated with thyroid nodules and cancer, hyper- and hypothyroidism, and menopause
• Describe differing management strategies for patients with endocrine hypertension, adrenal insufficiency, congenital adrenal hyperplasia, hypoglycemia, and obesity
• Review case management issues for endocrine surgery and pediatric patients with endocrine disorders
• Describe the potential impact of endocrine disorders in transgender patients
• Summarize diagnosis and management strategies for disorders of the thyroid, pituitary, and adrenal glands
• Summarize management issues for metabolic bone disease, osteoporosis, vitamin D deficiency, and hyper/hypocalcemia
• Explain the different management strategies for male hypogonadism and female hypogonadism
• Describe diabetes complications and the impact of new insulin and incretin therapies

Intended Audience

This activity is designed for practicing endocrinologists who want to stay current or preparing for assessment. Residents and fellows who are preparing for initial certification, board and ABIM certification and other healthcare professionals with an interest in endocrinology, metabolism and diabetes and want to learn the latest developments.

Topics:

• Thyroid Nodules and Cancer – Hossein Gharib, MD
• Menopause – A Pause for Thought – Keren Zhou, MD
• Thyroid Board Simulation – Victor Bernet, MD
• Genetics and Endocrinology – S. Sethu K. Reddy, MD, MBA, FACP, MACE
• Endocrine Hypertension – Richard J. Auchus, MD
• Cushing’s and Adrenal Insufficiency – Prathiba P. Rao, MD
• Congenital Adrenal Hyperplasia of CAH in Adults – Donald Zimmerman, MD, FACE
• Case Management Studies in Endocrine Surgery – Allan Siperstein, MD
• Hypoglycemia Evaluation – Elias S. Siraj, MD
• Obesity Therapy – Marcio Griebeler, MD
• Pediatric Endocrinology Board Questions – Anzar Haider, MD
• DI/SIADH – Joseph Verbalis, MD
• Pituitary Disorders – Mark E. Molitch, MD
• Board Simulation – Pituitary – Divya Yogi-Morren, MD
• Osteoporosis and Vitamin D Deficiency – Sabashini Ramchand, MBBS
• Unusual Bone Disorders – Leila Khan, MD
• Metabolic Bone Disease – Board Simulation – Mario Skugor, MD
• Hypocalcemia and Hypercalcemia – Michael A. Levine, MD, FAAP, FACP, MACE
• Endocrine Oncology – Christian Nasr, MD
• Endocrinology and Pregnancy – Adi Mehta, MD
• Male Hypogonadism – Charles Faiman, MD
• Amenorrhea – Marjan Attaran, MD
• Polycystic Ovarian Syndrome – Vinni Makin, MD
• Transgender Management – Ricardo Correa Marquez, MD
• Endocrine Millionaire – S. Sethu K. Reddy, MD, MBA, FACP, MACE
• Board Simulation Potpourri – Mona Gossmann, MD
• Advanced Lipidology – Abhayjit Singh, MD
• Dyslipidemia – Practice Guidelines – Dennis Bruemmer, MD, PhD
• Diabetes Therapeutics – From New Insulins to Incretins – Robert Zimmerman, MD, FACE
• Preventing Diabetes Complications – Treat to Target and Outcome – Kevin Pantalone, DO, ECNU, FACE